STRATA Skin Sciences

64 articles about STRATA Skin Sciences

• STRATA Skin Sciences Announces First Patients Treated in TheraClear®X Clinical Study for Acne

  5/30/2023

  STRATA Skin Sciences, Inc. announced that the first six patients have been treated in the TheraClear®X open label, single-arm, clinical research study led by Glynis Ablon, MD, FAAD.

• STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Music City Scale Symposium for Cosmetic Advances and Laser Education

  5/19/2023

  STRATA Skin Sciences, Inc. today announced Joel L. Cohen, MD (FAAD, FACMS), Director of AboutSkin Dermatology in Greenwood Village, Colorado will be demonstrating the TheraClear ® X device at the Music City Scale Symposium for Cosmetic Advances and Laser Education at the Grand Hyatt.

• STRATA Skin Sciences Reports First Quarter 2023 Revenue

  5/15/2023

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the first quarter ended March 31, 2023.

• STRATA Skin Sciences Enters India Market with Exclusive Distribution Agreement with Spectra Medical

  5/15/2023

  STRATA Skin Sciences, Inc. announced it has entered into an exclusive, three-year agreement with Spectra Medical India Pvt Ltd., a distribution company representing medical laser and aesthetic equipment manufacturers, for the distribution of TheraClear®X, VTRAC®, and XTRAC® in India.

• STRATA Skin Sciences to Participate in Inaugural EF Hutton Global Conference

  5/8/2023

  STRATA Skin Sciences, Inc. announced the company will participate in the Inaugural EF Hutton Global Conference at The Plaza Hotel in New York City from May 10-11, 2023.

• STRATA Skin Sciences to Report First Quarter 2023 Financial Results on May 15, 2023

  5/2/2023

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its first quarter 2023 financial results on Monday, May 15, 2023.

• STRATA Skin Sciences Pre-Announces First Quarter 2023 Results

  4/12/2023

  STRATA Skin Sciences, Inc. announced preliminary revenue for the first quarter of 2023 in the range of $7.3 - $7.8 million and is expected to be the strongest first-quarter results since the first quarter of 2016.

• STRATA Skin Sciences Reports Record Fourth Quarter 2022 Revenue

  3/31/2023

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the fourth quarter and full year ended December 31, 2022.

• STRATA Skin Sciences Reschedules Fourth Quarter 2022 Conference Call and Webcast to Friday, March 31, 2023

  3/28/2023

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it will release its fourth quarter 2022 financial results along with its Form 10-K on Friday, March 31, 2023.

• STRATA Skin Sciences to Report Fourth Quarter 2022 Financial Results on March 28, 2023

  3/14/2023

  STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth quarter 2022 financial results on Tuesday, March 28, 2023.

• STRATA Skin Sciences Announces Regaining Compliance with NASDAQ’S Minimum Price Rule

  2/27/2023

  STRATA Skin Sciences, Inc. announced that it had been notified by Nasdaq that Strata has regained compliance with the Nasdaq listing requirements regarding minimum bid price, Rule 5550.

• STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Inaugural Winter Clinical Conference

  2/16/2023

  STRATA Skin Sciences, Inc. announced that Joel L. Cohen, MD, Director of AboutSkin Dermatology in Greenwood Village, Colorado, will be speaking during the live patient demonstration of the TheraClear®X device, FDA-cleared for the treatment of mild-to-moderate acne, including comedonal, pustular, and inflammatory acne vulgaris, at the inaugural Winter Clinical Conference at the InterContinental in Miami, Florida from February 17-20, 2023.

• STRATA Skin Sciences Announces Poster Accepted at ODAC Dermatology, Aesthetic & Surgical Conference

  1/13/2023

  STRATA Skin Sciences, Inc. today announced a poster titled “Advancement of Personalized Photopneumatic Therapy for Rapid, Visible Improvement In Patients Mild to Moderate Acne” was accepted at the ODAC Dermatology, Aesthetic & Surgical Conference held at the JW Marriott Grande Lakes.

• STRATA Skin Sciences to Participate at Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference

  12/2/2022

  STRATA Skin Sciences, Inc. announced the company will present at the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference being held at the Fontainebleau Miami Beach, Miami, Florida on December 8, 2022.

• STRATA Skin Sciences Reports Strong Third Quarter 2022 Financial Results

  11/9/2022

  STRATA Skin Sciences, Inc. announced strong financial results for the third quarter ended September 30, 2022.

• STRATA Skin Sciences to Report Third Quarter 2022 Financial Results on November 9, 2022

  10/26/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it plans to release its third quarter 2022 financial results on Wednesday, November 9, 2022.

• STRATA Skin Sciences to Participate at Upcoming October 2022 Investor Conferences

  10/6/2022

  STRATA Skin Sciences, Inc. announced the company will present at the Midcap Rodeo: Windy City Roundup 2022 and the LD Micro Main Event XV.

• STRATA Skin Sciences to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

  8/22/2022

  STRATA Skin Sciences, Inc. today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

• STRATA Skin Sciences Reports Second Quarter 2022 Financial Results

  8/10/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the second quarter ended June 30, 2022.

• STRATA Skin Sciences Announces Upcoming KOL Call Hosted by Ladenburg Thalmann

  8/2/2022

  STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that the Company’s XTRAC Excimer Laser will be highlighted in an upcoming Key Opinion Leader Call hosted by Ladenburg Thalmann.